Navigation Links
Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat
Date:3/12/2013

SAN DIEGO, March 12, 2013 /PRNewswire/ -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, announced today that the first patient has been treated with LIPO-202 (Salmeterol Xinafoate for Injection) in its 500-patient Phase 2b "RESET" trial.  LIPO-202, Lithera's lead product candidate, is a novel injectable pharmaceutical product designed to produce localized reduction of subcutaneous fat.

"Initiating the RESET trial is a significant milestone for Lithera and in the development of LIPO-202 as a non-ablative treatment for the aesthetic reduction of subcutaneous abdominal fat," stated George W. Mahaffey , President and CEO of Lithera.  "Following our recent Series C financing, Lithera is focused on advancing LIPO-202 in the clinic as we see tremendous potential for the drug to address a significant opportunity in aesthetic medicine – the ability to offer a quick and minimally invasive 'lunch time' procedure with no patient down time that effectively reduces abdominal fat."  

RESET is a 500-patient, multi-center, randomized, placebo-controlled clinical trial designed to measure the effects of three different doses of LIPO-202, compared to placebo, on abdominal bulging due to excess subcutaneous fat in healthy, non-obese subjects.  Patients randomized into each of the four trial arms will receive subcutaneous injections spaced evenly across the abdomen once per week for eight weeks.  Trial endpoints include multiple qualitative and quantitative measures of bulge reduction, as well as key safety information.

"The RESET trial incorporates indication-specific objective and subjective efficacy measures, as well as a suitably large sample size in order to provide what we hope to be a very clear demonstration of LIPO-202's effectiveness and a definition of its optimal dos
'/>"/>

SOURCE Lithera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
3. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
6. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
7. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
10. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
11. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, announced that Edwards, ... served as an expert panelist at the invitation of ... Health to discuss medical device innovation at its hearing, ... Evidence Development and Communication." "Edwards has five ...
(Date:7/22/2014)... 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... 2014 second quarter financial results on Tuesday, August 5, ... management will host a live audio webcast immediately following ... provide a business and financial update and discuss second ... access the live audio webcast via the Investors & ...
(Date:7/22/2014)... July 22, 2014 Research and Markets ... Culture Market by Equipment, by Reagent, by Application - ... http://photos.prnewswire.com/prnh/20130307/600769 ... culture is one of the most important and widely ... largest application segment of the cell culture market in ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
(Date:7/23/2014)... July 23, 2014 As the body ages, ... slowly resulting in old muscle being replaced by fatty tissue. ... fat in the belly region, the most dangerous area of ... actually surrounds the internal organs and circulates through the liver ... conditions. , For this reason, Diet Doc’s staff of ...
(Date:7/23/2014)... QC (PRWEB) July 23, 2014 ... the features and benefits of the company’s latest ... ASEPTIX² Dual UV Disinfection System uses a primary ... high-touch surfaces with ultraviolet ‘C’ energy controlling (6 ... C. diff. in less than 10 minutes in ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 Woodland ... million Americans suffering from chronic bad breath that the condition ... they speak. , Dr. Saj Jivraj and Dr. Mamaly Reshad ... Hills, Calif., are concerned that some people may be overlooking ... often is a sign of an infection or chronic disease ...
(Date:7/23/2014)... ISI Telemanagement Solutions, Inc., a leading provider ... Analytics, a new product as part of their ... users the ability to uncover vital customer information buried ... well as chat sessions and social media announcements. While ... adding speech analytics on to a recording solution provides ...
(Date:7/23/2014)... Townsend Security, a leading authority in data privacy ... solutions now support two factor authentication. This major update ... on passwords as their only authentication mechanism. , Customers ... Factor Authentication software with the following Alliance solutions ... AES/400 – High performance, NIST validated AES encryption , ...
Breaking Medicine News(10 mins):Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 2Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 3Health News:Sanuvox Produces ASEPTIX² Movie Showcasing the Feature Benefits of the Company’s Latest Flagship Hospital Surface Disinfection System 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 5Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 3Health News:Townsend Security Brings Two Factor Authentication to Leading IBM i Security Solutions 2
... may contain higher levels of extremely small particles of ... than polluted outdoor air, scientists in Australia and Germany ... Environmental Science & Technology . Lidia Morawska ... the health effects of airborne ultrafine particles. Evidence suggests ...
... , , ATLANTA, Dec. 22 ... leader in automated revenue integrity solutions that improve healthcare providers, ... of first in the Revenue Cycle - Chargemaster Management market ... Software & Professional Services" report, published December 2009. KLAS is ...
... Dec. 22 After taking part in a ... Senators Max Baucus (D-MT), Christopher Dodd (D-CT) and Tom Harkin ... and President of the National Puerto Rican Coalition today issued ... Fantauzzi: , "We are on the threshold of legislation ...
... An international study authored by a UT Southwestern Medical ... works no better than a placebo in several other applications ... of a class of drugs used to increase red blood ... and anemia, but in a study of 4,038 patients, it ...
... mice, single treatment offered lifetime protection against inherited form of ... treatment with a new method of gene therapy may offer ... according to the results of a study in mice. , ... Alpha-1 Anti-trypsin Deficiency, caused by a mutation in the alpha-1 ...
... , , KANSAS CITY, Mo., Dec. ... financial services industry, insurance businesses have not been immune to ... companies leaked into the business side of insurance, creating skepticism ... able to plan and protect themselves and their families. ...
Cached Medicine News:Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 2Health News:Craneware's Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year 3Health News:National Puerto Rican Coalition Urges Passage of Senate Health Bill 2Health News:Anemia drug not helpful for kidney disease patients 2Health News:Gene Therapy Holds Promise for Emphysema 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 3Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 4
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... a minimally invasive, highly effective surgical alternative ... GYNECARE TVT is positioned close to the ... when needed, TVT provides tension-free support of ... procedure takes approximately 20 to 30 minutes, ...
... best of both worlds, the PeaceKeeper ... the latest addition to the Wet-Field ... cautery instruments for ophthalmic surgery. Combining ... aspiration and backflush functionality in a ...
...
Medicine Products: